Encision Inc
encision.comNo Longer Reporting
The company has not filed an annual or quarterly report since its Q2 FY2026 10-Q, filed Nov 13, 2025. Its latest SEC filing is a D from Sep 17, 2026.
10-Q for Q2 FY2026, filed Nov 13, 2025
The sections below describe the company as of the FY2025 annual report.
What Did They Do?
Markets shielded laparoscopic electrosurgical instruments and monitors for hospitals and surgical teams performing minimally invasive procedures.
10-K for FY2025, filed Jul 10, 2025Encision Inc. (“Encision”, “we”, “us”, “our” or the “Company"), a medical device company based in Boulder, Colorado, has developed and…View ↗
Our patented AEM technology provides surgeons with the desired tissue effects of cutting and coagulating tissue in laparoscopic procedures…View ↗
The AEM system comprises shielded 5mm AEM Instruments and an AEM monitor. The AEM Instruments are designed to function identically to the…View ↗
How Did They Make Money?
Hospitals and stocking distributors buy AEM instruments and monitors, with the sale completed at shipment; external customers are billed for engineering work based on time and materials as it is performed.
10-K for FY2025, filed Jul 10, 2025When a hospital decides to use our AEM technology, we make recurring sales to such hospitals for replacement instruments. Sales from…View ↗
Revenue Recognition. We record revenue at a single point in time, when control is transferred to the customer, which is consistent with…View ↗
Net Service revenue. Net service revenue for FY25 was $337,628 and for FY24 net service revenue was $153,913. Net service revenue for FY24…View ↗
-
10-K for FY2025, filed Jul 10, 2025
FY2025 revenue by product or service ↗
$6.6M
-
10-K for FY2025, filed Jul 10, 2025
$6.6M ↗
| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Product
Sold outright
10-K for FY2025, filed Jul 10, 2025 |
95%
FY2022: 90%
|
Product, FY2025
$6.2M Sources
|
Sold outright |
|
Service
Recurring
|
5.2%
FY2022: 9.8%
|
Service, FY2025
$337.6K Sources
|
Recurring |
Who Were Their Customers?
Encision sells AEM products to hospitals and stocking distributors, using direct and independent sales representatives; it also performs engineering services for external entities.
10-K for FY2025, filed Jul 10, 2025When a hospital decides to use our AEM technology, we make recurring sales to such hospitals for replacement instruments. Sales from…View ↗
To cost-effectively expand market coverage, we focus on optimizing our distribution network, comprised of direct and independent sales…View ↗
Revenue Recognition. We record revenue at a single point in time, when control is transferred to the customer, which is consistent with…View ↗
Net Service revenue. Net service revenue for FY25 was $337,628 and for FY24 net service revenue was $153,913. Net service revenue for FY24…View ↗
Did Revenues Turn Into Profits?
No. It lost $220.2K in FY2025.
10-K for FY2025, filed Jul 10, 2025
−$172KView ↗
10-K for FY2025, filed Jul 10, 2025
−$220.2KView ↗
10-K for FY2025, filed Jul 10, 2025
−$109.4KView ↗
How Were They Changing?
- Net income
-
Sources
10-Q for Q2 FY2026, filed Nov 13, 2025
−$267.8KView ↗
- ▲ +57% (Loss)
- vs −$170.3K in Q2 FY2025
10-Q for Q2 FY2026, filed Nov 13, 2025
Open tableView ↗
-
Jan 29, 2026
Plans to deregister common stock and suspend SEC reporting
The company said a Form 15 filing would suspend its annual, quarterly and current-report obligations.
Sources
8-K, filed Jan 29, 2026
On January 29, 2026, Encision Inc. (the “Company”) announced that it plans to deregister its common stock and suspend its reporting…View ↗
-
Dec 12, 2025
CEO resigns; interim CEO appointed
Gregory Trudel resigned as CEO and President; Robert Fries was appointed interim President and CEO.
Sources
8-K, filed Dec 12, 2025
On December 8, 2025, Gregory Trudel also resigned as CEO, President and an executive officer of the Company.View ↗
Shrank. Revenue fell 13% in 4 years, from $7.5M in FY2021 to $6.6M in FY2025, about 3% a year.
Who Did They Compete With?
Competes with Medtronic, Johnson & Johnson, Olympus, and Lumenis
10-K for FY2025, filed Jul 10, 2025The electrosurgical device market is intensely competitive and tends to be dominated by a relatively small group of large and well-financed…View ↗
Loading...
